Efficacy of the hepatitis B vaccine alone in the prevention of hepatitis B perinatal transmission in infants born to hepatitis B e antigen-negative carrier mothers
Background: Vertical mother-to-child transmission (MTCT) of the hepatitis B virus (HBV) remains an important issue. Timely administration of hepatitis B immunoglobulin (HBIG) and of the HBV vaccine is effective in preventing MTCT in infants born to HBV-infected mothers. However, HBIG is often not ea...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2022-06-01
|
| Series: | Journal of Virus Eradication |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2055664022000140 |
| _version_ | 1828333708607750144 |
|---|---|
| author | Wenjun Zhang Chenyu Xu Yanjing Rui Jie Chen Tingmei Chen Yimin Dai Biyun Xu Yali Hu Junhao Chen Yi-Hua Zhou |
| author_facet | Wenjun Zhang Chenyu Xu Yanjing Rui Jie Chen Tingmei Chen Yimin Dai Biyun Xu Yali Hu Junhao Chen Yi-Hua Zhou |
| author_sort | Wenjun Zhang |
| collection | DOAJ |
| description | Background: Vertical mother-to-child transmission (MTCT) of the hepatitis B virus (HBV) remains an important issue. Timely administration of hepatitis B immunoglobulin (HBIG) and of the HBV vaccine is effective in preventing MTCT in infants born to HBV-infected mothers. However, HBIG is often not easily available in low-income countries or regions. Methods: We compared in a retrospective cohort study the HBV vaccine efficacy alone and in combination with HBIG in preventing vertical MTCT in infants born to HBeAg-negative carrier mothers in Jiangsu province, China. Based on the administration of the HBV vaccine and HBIG shortly after birth, children were divided into two groups: Group 1, administration of the HBV vaccine alone, and Group 2, concurrent use of HBIG and of the HBV vaccine. Results: A total of 620 infants born to HBeAg-negative carrier mothers were enrolled into this study. Group 1 included 195 children who had received the HBV vaccine alone after birth, and Group 2, 425 children who had received both HBIG and the HBV vaccine. Children were followed up to the age of 68 and 42 months, respectively. MTCT of HBV occurred in 0% (0/195) in Group 1 (HBV vaccine alone) and 0% (0/425) in Group 2 (HBV vaccine and HBIG) (p = 1.00). Conclusion: In this retrospective cohort study, we found that HBV vaccination alone shortly after birth was effective in preventing MTCT of HBV in infants born to HBeAg-negative carrier mothers. |
| first_indexed | 2024-04-13T21:23:34Z |
| format | Article |
| id | doaj.art-d1a664d0c3ac4b43aafd7b23668a0128 |
| institution | Directory Open Access Journal |
| issn | 2055-6640 |
| language | English |
| last_indexed | 2024-04-13T21:23:34Z |
| publishDate | 2022-06-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Journal of Virus Eradication |
| spelling | doaj.art-d1a664d0c3ac4b43aafd7b23668a01282022-12-22T02:29:23ZengElsevierJournal of Virus Eradication2055-66402022-06-0182100076Efficacy of the hepatitis B vaccine alone in the prevention of hepatitis B perinatal transmission in infants born to hepatitis B e antigen-negative carrier mothersWenjun Zhang0Chenyu Xu1Yanjing Rui2Jie Chen3Tingmei Chen4Yimin Dai5Biyun Xu6Yali Hu7Junhao Chen8Yi-Hua Zhou9Department of Laboratory Medicine, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, 210008, ChinaDepartment of Obstetrics and Gynecology, Zhenjiang Fourth People's Hospital, Zhenjiang, ChinaDepartment of Obstetrics and Gynecology, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, ChinaDepartment of Obstetrics and Gynecology, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, ChinaDepartment of Obstetrics and Gynecology, Zhenjiang Fourth People's Hospital, Zhenjiang, ChinaDepartment of Obstetrics and Gynecology, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, ChinaDepartment of Biomedical Statistics, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, ChinaDepartment of Obstetrics and Gynecology, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, China; Corresponding author.Department of Laboratory Medicine, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, 210008, China; Corresponding author.Department of Laboratory Medicine, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, 210008, China; Department of Infectious Diseases, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, China; Corresponding author. Departments of Laboratory Medicine and Infectious Diseases, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, China.Background: Vertical mother-to-child transmission (MTCT) of the hepatitis B virus (HBV) remains an important issue. Timely administration of hepatitis B immunoglobulin (HBIG) and of the HBV vaccine is effective in preventing MTCT in infants born to HBV-infected mothers. However, HBIG is often not easily available in low-income countries or regions. Methods: We compared in a retrospective cohort study the HBV vaccine efficacy alone and in combination with HBIG in preventing vertical MTCT in infants born to HBeAg-negative carrier mothers in Jiangsu province, China. Based on the administration of the HBV vaccine and HBIG shortly after birth, children were divided into two groups: Group 1, administration of the HBV vaccine alone, and Group 2, concurrent use of HBIG and of the HBV vaccine. Results: A total of 620 infants born to HBeAg-negative carrier mothers were enrolled into this study. Group 1 included 195 children who had received the HBV vaccine alone after birth, and Group 2, 425 children who had received both HBIG and the HBV vaccine. Children were followed up to the age of 68 and 42 months, respectively. MTCT of HBV occurred in 0% (0/195) in Group 1 (HBV vaccine alone) and 0% (0/425) in Group 2 (HBV vaccine and HBIG) (p = 1.00). Conclusion: In this retrospective cohort study, we found that HBV vaccination alone shortly after birth was effective in preventing MTCT of HBV in infants born to HBeAg-negative carrier mothers.http://www.sciencedirect.com/science/article/pii/S2055664022000140Hepatitis B virusMother-to-child transmissionHepatitis B vaccineHepatitis B immunoglobulinHepatitis B e AntigenEfficacy assessment |
| spellingShingle | Wenjun Zhang Chenyu Xu Yanjing Rui Jie Chen Tingmei Chen Yimin Dai Biyun Xu Yali Hu Junhao Chen Yi-Hua Zhou Efficacy of the hepatitis B vaccine alone in the prevention of hepatitis B perinatal transmission in infants born to hepatitis B e antigen-negative carrier mothers Journal of Virus Eradication Hepatitis B virus Mother-to-child transmission Hepatitis B vaccine Hepatitis B immunoglobulin Hepatitis B e Antigen Efficacy assessment |
| title | Efficacy of the hepatitis B vaccine alone in the prevention of hepatitis B perinatal transmission in infants born to hepatitis B e antigen-negative carrier mothers |
| title_full | Efficacy of the hepatitis B vaccine alone in the prevention of hepatitis B perinatal transmission in infants born to hepatitis B e antigen-negative carrier mothers |
| title_fullStr | Efficacy of the hepatitis B vaccine alone in the prevention of hepatitis B perinatal transmission in infants born to hepatitis B e antigen-negative carrier mothers |
| title_full_unstemmed | Efficacy of the hepatitis B vaccine alone in the prevention of hepatitis B perinatal transmission in infants born to hepatitis B e antigen-negative carrier mothers |
| title_short | Efficacy of the hepatitis B vaccine alone in the prevention of hepatitis B perinatal transmission in infants born to hepatitis B e antigen-negative carrier mothers |
| title_sort | efficacy of the hepatitis b vaccine alone in the prevention of hepatitis b perinatal transmission in infants born to hepatitis b e antigen negative carrier mothers |
| topic | Hepatitis B virus Mother-to-child transmission Hepatitis B vaccine Hepatitis B immunoglobulin Hepatitis B e Antigen Efficacy assessment |
| url | http://www.sciencedirect.com/science/article/pii/S2055664022000140 |
| work_keys_str_mv | AT wenjunzhang efficacyofthehepatitisbvaccinealoneinthepreventionofhepatitisbperinataltransmissionininfantsborntohepatitisbeantigennegativecarriermothers AT chenyuxu efficacyofthehepatitisbvaccinealoneinthepreventionofhepatitisbperinataltransmissionininfantsborntohepatitisbeantigennegativecarriermothers AT yanjingrui efficacyofthehepatitisbvaccinealoneinthepreventionofhepatitisbperinataltransmissionininfantsborntohepatitisbeantigennegativecarriermothers AT jiechen efficacyofthehepatitisbvaccinealoneinthepreventionofhepatitisbperinataltransmissionininfantsborntohepatitisbeantigennegativecarriermothers AT tingmeichen efficacyofthehepatitisbvaccinealoneinthepreventionofhepatitisbperinataltransmissionininfantsborntohepatitisbeantigennegativecarriermothers AT yimindai efficacyofthehepatitisbvaccinealoneinthepreventionofhepatitisbperinataltransmissionininfantsborntohepatitisbeantigennegativecarriermothers AT biyunxu efficacyofthehepatitisbvaccinealoneinthepreventionofhepatitisbperinataltransmissionininfantsborntohepatitisbeantigennegativecarriermothers AT yalihu efficacyofthehepatitisbvaccinealoneinthepreventionofhepatitisbperinataltransmissionininfantsborntohepatitisbeantigennegativecarriermothers AT junhaochen efficacyofthehepatitisbvaccinealoneinthepreventionofhepatitisbperinataltransmissionininfantsborntohepatitisbeantigennegativecarriermothers AT yihuazhou efficacyofthehepatitisbvaccinealoneinthepreventionofhepatitisbperinataltransmissionininfantsborntohepatitisbeantigennegativecarriermothers |